Abbott Laboratories Stock Swiss Exchange
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.00 CHF | +0.71% |
|
-2.07% | -28.28% |
| Market Cap | 154B 134B 124B 116B 218B 14,513B 219B 1,472B 571B 7,152B 578B 566B 24,790B | P/E 2026 * |
22.2x | P/E 2027 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 166B 144B 133B 125B 234B 15,618B 236B 1,584B 615B 7,697B 622B 609B 26,678B | EV / Sales 2026 * |
3.3x | EV / Sales 2027 * | 2.97x |
| Free-Float |
86.73% | Yield 2026 * |
2.88% | Yield 2027 * | 3.07% |
Last Transcript: Abbott Laboratories
| 1 day | +0.71% | ||
| 1 week | -2.07% | ||
| Current month | +5.19% | ||
| 1 month | +4.41% | ||
| 3 months | -17.92% | ||
| 6 months | -28.28% | ||
| Current year | -28.28% |
| 1 week | 70.5 |  | 71 |
| 1 month | 67.5 | | 74.5 |
| Current year | 65 | | 100 |
| 1 year | 65 | | 106 |
| 3 years | 65 | | 106 |
| 5 years | 65 | | 128 |
| 10 years | 34.75 | | 128 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | -2.07% | - | - | 154B | |
| +1.54% | -1.23% | -7.45% | -11.00% | 102B | |
| -4.45% | +3.12% | +59.84% | +56.09% | 59.25B | |
| -1.90% | -3.43% | -8.40% | +48.53% | 52.89B | |
| +1.67% | -2.29% | -14.60% | -44.33% | 39.67B | |
| -1.32% | -3.20% | - | - | 30.39B | |
| +1.74% | -3.69% | -10.54% | -44.30% | 27.96B | |
| +1.35% | -0.72% | +50.47% | -9.42% | 23.17B | |
| -1.53% | +1.14% | -15.03% | -5.42% | 20.7B | |
| -0.42% | -6.15% | -18.58% | -31.65% | 18.48B | |
| Average | -0.26% | -1.10% | +4.46% | -5.19% | 41.6B | |
| Weighted average by Cap. | -0.06% | -0.03% | +5.77% | +2.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.29B 43.82B 40.39B 37.99B 71.08B 4,740B 71.58B 481B 187B 2,336B 189B 185B 8,096B | 54.79B 47.74B 44.01B 41.39B 77.44B 5,164B 77.99B 524B 203B 2,545B 206B 201B 8,821B |
| Net income | 7.02B 6.12B 5.64B 5.3B 9.92B 661B 9.99B 67.07B 26.05B 326B 26.35B 25.78B 1,130B | 8.39B 7.31B 6.74B 6.34B 11.86B 791B 11.94B 80.2B 31.14B 390B 31.5B 30.83B 1,351B |
| Net Debt | 11.73B 10.22B 9.42B 8.86B 16.57B 1,105B 16.69B 112B 43.52B 545B 44.02B 43.07B 1,888B | 8.88B 7.74B 7.13B 6.71B 12.55B 837B 12.64B 84.88B 32.97B 413B 33.34B 32.63B 1,430B |
| Date | Price | Change |
|---|---|---|
| 18/06/26 | 71.00 CHF | 0.00% |
| 17/06/26 | 71.00 CHF | 0.00% |
| 16/06/26 | 71.00 CHF | +0.71% |
| 15/06/26 | 70.50 CHF | -2.76% |
| 12/06/26 | 72.50 CHF | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
